Analog Devices — Nov 26, 2024 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000006281-24-000202
Showing in the filing
Nonoperating expenses (Reported)
“~ $60 Million”
Period
Q1 FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 8
Reported operating margin for Q1 FY2025
“approximately 22.0%, +/- 130 bps”
Adjusted operating margin for Q1 FY2025
“approximately 40.0%, +/- 100 bps”
Reported EPS for Q1 FY2025
“$0.80, +/- $0.10”
Adjusted EPS for Q1 FY2025
“$1.53, +/- $0.10”
Quarterly cash dividend
“$0.92 per outstanding share of common stock”
Revenue (Reported) for Q1 FY2025
“$2.35 Billion (+/- $100 Million)”
Nonoperating expenses (Reported) for Q1 FY2025
“~ $60 Million”
Tax rate (Reported) for Q1 FY2025
“12% - 14%”
Exhibit 99.1 · the passage around this item
… earlier in the release
RECONCILIATION OF PROJECTED GAAP TO NON-GAAP RESULTS (Unaudited) Three Months Ending February 1, 2025 Reported Adjusted Revenue $2.35 Billion $2.35 Billion (+/- $100 Million) (+/- $100 Million) Operating margin 22.0% 40.0% (1) (+/-130 bps) (+/-100 bps) Nonoperating expenses ~ $60 Million ~ $60 Million Tax rate 12% - 14% 12% - 14% (2) Earnings per share $0.80 $1.53 (3) (+/- $0.10) (+/- $0.10) (1) Includes $424 million of adjustments related to acquisition related expenses, as defined in the Non-GAAP Financial Information section of this press release. (2) Includes $55 million of tax effects associated with the adjustments for acquisition related expenses noted above. (3) Includes $0.73 of adjustments related to the net impact of acquisition related expenses and the tax effects on those items. For more information, please contact: Investor Contact: Analog Devices, Inc. Mr. Michael Lucarelli Vice President, Investor Relations and FP&A 781-461-3282 investor.relations@analog.com Media Contacts: Analog Devices, Inc. Ms. Ferda Millan Global PR & External Communications Ferda.Millan@analog.com
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.